Objective: To describe the prevalence and incidence of endometriosis and to estimate the risk of cardiovascular outcomes in women with endometriosis. Design: Population-based cohort study using The Health Improvement Network database. Setting: UK primary care. Population: Women aged 16–50 years were followed from 1995 to 2018. Methods: Adjusted hazard ratios (aHR) for cardiovascular outcomes comparing women with endometriosis with those without endometriosis were estimated using multivariable Cox regression models. Prevalence and incidence of endometriosis were estimated using annual (1998–2017) sequential cross-sectional and cohort studies, respectively. Main outcome measure: The primary outcome was composite cardiovascular disease (CVD) including, ischaemic heart disease (IHD), heart failure (HF) and cerebrovascular disease. Secondary outcomes were arrhythmia, hypertension and all-cause mortality. Results: In all, 56 090 women with endometriosis and 223 669 matched controls without endometriosis were included in the analysis of cardiovascular risk. Compared with women without endometriosis, the aHR for cardiovascular outcomes among women with endometriosis were: composite CVD 1.24 (95% CI 1.13–1.37); IHD 1.40 (95% CI 1.22–1.61); cerebrovascular disease 1.19 (95% CI 1.04–1.36); HF 0.76 (95% CI 0.54–1.07); arrhythmia 1.26 (95% CI 1.11–1.43); hypertension 1.12 (95% CI 1.07–1.17) and all-cause mortality 0.66 (95% CI 0.59–0.74). The incidence of endometriosis was 12.3 per 10 000 person-years in 1998 and 11.5 per 10 000 person-years in 2017. The prevalence of endometriosis increased from 119.7 per 10 000 population in 1998 to 201.3 per 10 000 population in 2017. Conclusion: Endometriosis is associated with an increased risk of cardiovascular outcomes. Young women with endometriosis are a potential target for CVD risk assessment and prevention. Tweetable abstract: Endometriosis is associated with increased risk of cardiovascular outcomes: a UK retrospective matched cohort study.
|Journal||BJOG: An International Journal of Obstetrics & Gynaecology|
|Early online date||8 Mar 2021|
|Publication status||E-pub ahead of print - 8 Mar 2021|
Bibliographical noteFunding Information:
KN reports grants from MRC and HDR UK outside the submitted work. NJA reports grants from MRC UKRI and NIHR RfPB outside the submitted work. The remaining authors have nothing to disclose. Completed disclosure of interests form available to view online as supporting information.
© 2021 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.
- cardiovascular disease
ASJC Scopus subject areas
- Obstetrics and Gynaecology